Teens with infections get One-Time dose of experimental antibiotic combo
NCT ID NCT07092813
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This early-stage study is testing whether a single dose of an experimental antibiotic (sulopenem etzadroxil plus probenecid) is safe and tolerable in 12 adolescents already receiving standard antibiotics for a bacterial infection. Researchers will measure how the drug moves through the body by collecting blood and urine samples over 12 hours. The goal is to gather safety and drug-level data, not to treat the infection itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS AFTER ORAL INTAKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical facility
RECRUITINGLittle Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.